BIOMAT Database Logo BIOMAT Database Logo

[The mean prothrombin activity during anticoagulant treatment. Significance and clinical importance]. 1965

P De Nicola, and P L Cipolli

UI MeSH Term Description Entries
D011516 Prothrombin A plasma protein that is the inactive precursor of thrombin. It is converted to thrombin by a prothrombin activator complex consisting of factor Xa, factor V, phospholipid, and calcium ions. Deficiency of prothrombin leads to hypoprothrombinemia. Coagulation Factor II,Factor II,Blood Coagulation Factor II,Differentiation Reversal Factor,Factor II, Coagulation,Factor, Differentiation Reversal,II, Coagulation Factor
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000925 Anticoagulants Agents that prevent BLOOD CLOTTING. Anticoagulant Agent,Anticoagulant Drug,Anticoagulant,Anticoagulant Agents,Anticoagulant Drugs,Anticoagulation Agents,Indirect Thrombin Inhibitors,Agent, Anticoagulant,Agents, Anticoagulant,Agents, Anticoagulation,Drug, Anticoagulant,Drugs, Anticoagulant,Inhibitors, Indirect Thrombin,Thrombin Inhibitors, Indirect
D066298 In Vitro Techniques Methods to study reactions or processes taking place in an artificial environment outside the living organism. In Vitro Test,In Vitro Testing,In Vitro Tests,In Vitro as Topic,In Vitro,In Vitro Technique,In Vitro Testings,Technique, In Vitro,Techniques, In Vitro,Test, In Vitro,Testing, In Vitro,Testings, In Vitro,Tests, In Vitro,Vitro Testing, In

Related Publications

P De Nicola, and P L Cipolli
Specific determinations of prothrombin during anticoagulant treatment.
January 1972, Acta medica Scandinavica,
P De Nicola, and P L Cipolli
CLINICAL SIGNIFICANCE OF PROTHROMBIN DEFICIENCY AND ITS TREATMENT.
November 1941, Annals of surgery,
P De Nicola, and P L Cipolli
[Prothrombin time and Thrombotest in anticoagulant treatment].
November 1968, Nederlands tijdschrift voor geneeskunde,
P De Nicola, and P L Cipolli
Prothrombin and accessory factors; clinical significance.
February 1953, The American journal of medicine,
P De Nicola, and P L Cipolli
[Clinical significance of prothrombin utilization].
January 1955, Polskie Archiwum Medycyny Wewnetrznej,
P De Nicola, and P L Cipolli
[Clinical significance of prothrombin time].
December 1989, Nihon rinsho. Japanese journal of clinical medicine,
P De Nicola, and P L Cipolli
The clinical significance of anti-prothrombin antibodies for risk assessment of thromboembolism in patients with lupus anticoagulant.
January 2007, Thrombosis research,
P De Nicola, and P L Cipolli
Inhibition of the anticoagulant activity of protein S by prothrombin.
December 1988, The Journal of clinical investigation,
P De Nicola, and P L Cipolli
[Prothrombin level change during treatment of acute and subacute regional inflammations. (Prognostic significance of prothrombin level)].
March 1953, Magyar noorvosok lapja,
P De Nicola, and P L Cipolli
[The lupus anticoagulant and its clinical significance].
January 1989, Orvosi hetilap,
Copied contents to your clipboard!